A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+metastatic breast cancer progressing on trastuzumab therapy

被引：37
|
作者：
O'Shaughnessy, J.
Blackwell, K. L.
Burstein, H.
Storniolo, A. M.
Sledge, G.
Baselga, J.
Koehler, M.
Laabs, S.
Florance, A.
Roychowdhury, D.
机构：
[1] Baylor Sammons Canc Ctr, Dallas, TX USA
[2] Duke Univ, Med Ctr, Raleigh, NC USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[5] Vall Hebron Univ Hosp, Barcelona, Spain
[6] GlaxoSmithKline, Collegeville, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1015
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Updated Survival Analysis of a Randomized Study of Lapatinib Alone or in Combination with Trastuzumab in Women with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab Therapy
    Blackwell, K. L.
    Burstein, H. J.
    Sledge, G. W.
    Stein, S.
    Ellis, C.
    Casey, M.
    Baselga, J.
    O'Shaughnessy, J.
    CANCER RESEARCH, 2009, 69 (24) : 499S - 499S
  • [2] Study of lapatinib (T) in combination with trastuzumab (T) in women heavily pretreated with HER2-positive metastatic breast cancer (MBC).
    Salvador, Javier
    Ruiz Borrego, Manuel
    Valero, Maria
    Bayo, Juan L.
    De La Cruz-Merino, Luis
    Carabantes, FRancisco
    Rodriguez de la Borbolla, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF LAPATINIB IN COMBINATION WITH TRASTUZUMAB AND AS MONOTHERAPY AFTER PROGRESSION ON TRASTUZUMAB IN HEAVILY PRETREATED ERBB2+METASTATIC BREAST CANCER (MBC)
    Blackwell, K. L.
    Burstein, H. J.
    Storniolo, A. M.
    Rugo, H.
    Sledge, G.
    Koehler, M.
    Ellis, C.
    Casey, M.
    Baselga, J.
    Shaughnessy, J. O.
    ANNALS OF ONCOLOGY, 2008, 19 : 64 - 64
  • [4] Study of the combination gemcitabine and trastuzumab in the treatment of HER2+metastatic breast cancer
    Menjon-Beltran, S.
    Olivencia-Dueso, R.
    Gonzalez-Jimenez, E.
    Titos, M. J.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [5] Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
    Blackwell, Kimberly L.
    Burstein, Harold J.
    Storniolo, Anna Maria
    Rugo, Hope
    Sledge, George
    Koehler, Maria
    Ellis, Catherine
    Casey, Michelle
    Vukelja, Svetislava
    Bischoff, Joachim
    Baselga, Jose
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1124 - 1130
  • [6] Combination of trastuzumab and gemcitabine as salvage therapy in heavily pretreated patients with metastatic breast cancer
    Bartsch, R.
    Wenzel, C.
    Pluschnig, U.
    Altorjai, G.
    Dubsky, P.
    Scheurer, R.
    Rottenfusser, A.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 179
  • [7] Lapatinib with trastuzumab for heavily treated HER2-positive metastatic breast cancer (mBC).
    Sotelo, Miguel J.
    Manso, Luis
    Garcia Saenz, Jose Angel
    Ciruelos, Eva M.
    Moreno, Fernando
    Mendiola, Cesar
    Callata, Hector
    Ghanem, Ismael
    Cabezas, Santiago
    Gonzalez-Larriba, Jose-Luis
    Diaz Rubio, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Altorjai, Gabriela
    Pluschnig, Ursula
    Rudas, Margaretha
    Mader, Robert M.
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3853 - 3858
  • [9] S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+metastatic breast cancer
    Toh, U.
    Iwakuma, N.
    Mishima, M.
    Furukawa, M.
    Fujii, T.
    Ogo, E.
    Nakagawa, S.
    Tanaka, M.
    Akagi, Y.
    BREAST, 2015, 24 : S28 - S28
  • [10] Comparative effectiveness of trastuzumab emtansine versus lapatinib plus capecitabine for HER2+metastatic breast cancer
    Ramagopalan, Sreeram, V
    Pisoni, Riccardo
    Zenin, Aleksandr
    Rathore, Lokendra Singh
    Ray, Joshua
    Sammon, Cormac
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (07) : 595 - 602
12345